Particularităţi evolutive ale pneumoniei la persoanele imunocompromise (caz clinic)

Botnaru Victor; Rusu Doina; Zlepca Loreta; Haidarlî Ion; Bologa Vitalie; Munteanu Oxana

Conţinutul numărului revistei

Articolul precedent

Articolul urmator

1485

Ultima descărcare din IBN:
2023-05-26 13:15

SM ISO690:2012

BOTNARU, Victor, RUSU, Doina, ZLEPCA, Loreta, HAIDARLÎ, Ion, BOLOGA, Vitalie, MUNTEANU, Oxana. Particularităţi evolutive ale pneumoniei la persoanele imunocompromise (caz clinic) . In: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale, 2011, nr. 4(32), pp. 99-103. ISSN 1857-0011.

EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core

Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale

Numărul 4(32) / 2011 / ISSN 1857-0011

Particularităţi evolutive ale pneumoniei la persoanele imunocompromise (caz clinic)

Pag. 99-103

Botnaru Victor, Rusu Doina, Zlepca Loreta, Haidarlî Ion, Bologa Vitalie, Munteanu Oxana

IMSP Institutul de Ftiziopneumologie „Chiril Draganiuc“

Disponibil în IBN: 14 decembrie 2013

Descarcă PDF

Rezumat

Citomegalovirus hominis rar determină infecţii severe la persoanele cu imunitatea indemnă, pe când la persoanele imunocompromise este o cauză importantă de infecţii severe, deseori fatale. Pneumocystis jiroveci rămâne o cauză importantă de pneumonii severe la pacienţii HIV-infectaţi şi mai este în continuare principala boală defi nitoare de SIDA. Confi rmarea infecţiilor oportuniste este deseori difi cilă datorită manifestărilor clinice şi radiologice „şterse”, modeste, sau atipice, deseori coexistând şi un şir de alte infecţii şi boli asociate imunodefi cienţei.

Human cytomegalovirus rarely causes complications in the healthy individual, however immunocompromised patients are at risk of severe and often fatal cytomegalovirus disease. Pneumocystic pneumonia remains the most prevalent opportunistic infection and often the AIDS-defi - ning illness in patients infected with human immunodefi - ciency virus. Very often the confi rmation of the disease is diffi cult due to the lack of specifi city of clinical and radiological fi ndings, the frequent coexistence of multiple processes or infections in immunocompromised patients.

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-12247</cfResPublId>
<cfResPublDate>2011-10-04</cfResPublDate>
<cfVol>32</cfVol>
<cfIssue>4</cfIssue>
<cfStartPage>99</cfStartPage>
<cfISSN>1857-0011</cfISSN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/12247</cfURI>
<cfTitle cfLangCode='RO' cfTrans='o'>Particularităţi evolutive ale pneumoniei la persoanele imunocompromise (caz clinic)
</cfTitle>
<cfAbstr cfLangCode='RO' cfTrans='o'>Citomegalovirus hominis rar determină infecţii severe
la persoanele cu imunitatea indemnă, pe când la persoanele
imunocompromise este o cauză importantă de infecţii
severe, deseori fatale. Pneumocystis jiroveci rămâne o cauză
importantă de pneumonii severe la pacienţii HIV-infectaţi
şi mai este în continuare principala boală defi nitoare
de SIDA. Confi rmarea infecţiilor oportuniste este deseori
difi cilă datorită manifestărilor clinice şi radiologice „şterse”,
modeste, sau atipice, deseori coexistând şi un şir de
alte infecţii şi boli asociate imunodefi cienţei.</cfAbstr>
<cfAbstr cfLangCode='EN' cfTrans='o'>Human cytomegalovirus rarely causes complications
in the healthy individual, however immunocompromised
patients are at risk of severe and often fatal cytomegalovirus
disease. Pneumocystic pneumonia remains the most
prevalent opportunistic infection and often the AIDS-defi -
ning illness in patients infected with human immunodefi -
ciency virus. Very often the confi rmation of the disease is
diffi cult due to the lack of specifi city of clinical and radiological
fi ndings, the frequent coexistence of multiple processes
or infections in immunocompromised patients.</cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-11676</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-12017</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-28315</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-13539</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-10695</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-18864</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
</cfPers_ResPubl>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-11676</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-11676-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
<cfFamilyNames>Ботнару</cfFamilyNames>
<cfFirstNames>В.</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-12017</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-12017-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
<cfFamilyNames>Русу</cfFamilyNames>
<cfFirstNames>Д.</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-28315</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-28315-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
<cfFamilyNames>Zlepca</cfFamilyNames>
<cfFirstNames>Loreta</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-13539</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-13539-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
<cfFamilyNames>Хайдарлы</cfFamilyNames>
<cfFirstNames>И.</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-10695</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-10695-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
<cfFamilyNames>Болога</cfFamilyNames>
<cfFirstNames>В</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-18864</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-18864-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2011-10-04T24:00:00</cfStartDate>
<cfFamilyNames>Munteanu</cfFamilyNames>
<cfFirstNames>Oxana</cfFirstNames>
</cfPersName_Pers>
</cfPers>
</CERIF>